MeSH term
Frequency | Condition_Probility | 3T3 Cells | 3 | 0.0 |
Animals | 33 | 0.0 |
Base Sequence | 30 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Gene Silencing/*immunology | 2 | 100.0 |
Humans | 138 | 0.0 |
K562 Cells | 2 | 0.0 |
Mice | 20 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 103 | 0.0 |
Transfection | 10 | 0.0 |
Chromosome Aberrations | 3 | 0.0 |
In Situ Hybridization, Fluorescence/*methods | 2 | 2.0 |
Adolescent | 10 | 0.0 |
Adult | 28 | 0.0 |
Aged | 38 | 0.0 |
Aged, 80 and over | 14 | 0.0 |
Child | 6 | 0.0 |
DNA-Binding Proteins/*genetics | 43 | 2.0 |
Female | 44 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
*Gene Rearrangement | 10 | 4.0 |
In Situ Hybridization, Fluorescence | 19 | 0.0 |
Lymphoma, B-Cell/*genetics/mortality | 2 | 50.0 |
Lymphoma, Large-Cell, Diffuse/*genetics/mortality | 3 | 75.0 |
Male | 51 | 0.0 |
Middle Aged | 41 | 0.0 |
Prognosis | 7 | 0.0 |
Proto-Oncogene Proteins/*genetics | 44 | 4.0 |
Retrospective Studies | 3 | 0.0 |
Survival Rate | 5 | 0.0 |
Transcription Factors/*genetics | 43 | 2.0 |
DNA-Binding Proteins/genetics | 9 | 1.0 |
Immunoglobulin Variable Region/genetics | 2 | 1.0 |
Immunoglobulins, Heavy-Chain/genetics | 4 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 37 | 0.0 |
Tumor Cells, Cultured | 20 | 0.0 |
DNA Probes | 2 | 0.0 |
Gene Fusion | 3 | 3.0 |
In Situ Hybridization, Fluorescence/methods | 4 | 4.0 |
Nucleic Acid Hybridization/methods | 2 | 2.0 |
*Translocation, Genetic | 27 | 3.0 |
Blotting, Western | 2 | 0.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 2 | 3.0 |
Genes, Reporter | 6 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 7 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Proto-Oncogene Proteins/*chemistry/*metabolism | 2 | 11.0 |
Transcription Factors/*chemistry/*metabolism | 2 | 5.0 |
Zinc Fingers | 12 | 2.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 4 | 3.0 |
Gene Expression | 3 | 0.0 |
Immunohistochemistry | 16 | 0.0 |
Proto-Oncogene Proteins/biosynthesis/*genetics | 4 | 6.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 4 | 3.0 |
Chromosome Banding | 6 | 0.0 |
Cyclin D1/genetics | 2 | 3.0 |
Cytogenetic Analysis | 2 | 1.0 |
Immunoglobulins, Heavy-Chain/*genetics | 7 | 5.0 |
Lymphoma, B-Cell/*genetics | 23 | 32.0 |
Lymphoma, Follicular/genetics | 2 | 18.0 |
Polymerase Chain Reaction | 13 | 0.0 |
Proto-Oncogene Proteins/genetics | 8 | 1.0 |
Proto-Oncogene Proteins c-bcl-2/genetics | 3 | 2.0 |
Transcription Factors/genetics | 8 | 0.0 |
Comparative Study | 11 | 0.0 |
Models, Genetic | 4 | 0.0 |
B-Lymphocytes/*physiology | 2 | 1.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Transcription Factors/physiology | 2 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Cell Differentiation | 7 | 0.0 |
Cell Line | 18 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Repressor Proteins/biosynthesis/*genetics | 2 | 13.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
*Apoptosis | 3 | 0.0 |
B-Lymphocytes | 2 | 1.0 |
Binding Sites | 7 | 0.0 |
Consensus Sequence | 5 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 6 | 0.0 |
*Down-Regulation | 3 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Immunoenzyme Techniques | 5 | 0.0 |
Luciferases/genetics | 3 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Transcription Factors/genetics/*metabolism | 6 | 0.0 |
*Zinc Fingers | 6 | 2.0 |
*Chromosome Aberrations | 8 | 1.0 |
Karyotyping | 20 | 1.0 |
Lymphoma, Large-Cell, Diffuse/*genetics | 6 | 26.0 |
Chromosome Mapping | 13 | 0.0 |
Chromosomes, Human, Pair 3/*genetics | 8 | 3.0 |
DNA-Binding Proteins/*genetics/metabolism | 5 | 1.0 |
Exons/genetics | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 8 | 0.0 |
Genes, Reporter/genetics | 2 | 0.0 |
Introns/genetics | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 5 | 3.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Transcription Factors/*genetics/metabolism | 5 | 1.0 |
Translocation, Genetic/*genetics | 5 | 2.0 |
Mediastinal Neoplasms/*genetics | 2 | 33.0 |
Mutation/genetics | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 5 | 0.0 |
Carrier Proteins/analysis | 2 | 2.0 |
DNA-Binding Proteins/analysis | 3 | 3.0 |
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 3.0 |
Gene Rearrangement, T-Lymphocyte | 2 | 1.0 |
Herpesvirus 4, Human/isolation & purification | 4 | 6.0 |
In Situ Hybridization | 6 | 0.0 |
Ki-67 Antigen/analysis | 2 | 0.0 |
Micromanipulation | 2 | 11.0 |
Neoplasm Proteins/*analysis | 2 | 0.0 |
Neprilysin/*analysis | 2 | 16.0 |
Proto-Oncogene Proteins/analysis | 2 | 1.0 |
Transcription Factors/analysis | 3 | 4.0 |
Tumor Markers, Biological/*analysis | 3 | 0.0 |
Antineoplastic Combined Chemotherapy Protocols/therapeutic use | 2 | 0.0 |
Blotting, Southern | 12 | 0.0 |
Immunophenotyping | 12 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
Lymphoma, B-Cell/*genetics/pathology | 8 | 34.0 |
Lymphoma, Large-Cell, Diffuse/*genetics/pathology | 2 | 50.0 |
Lymphoma, B-Cell/genetics | 3 | 16.0 |
Mutation | 8 | 0.0 |
Chromosomes, Human, Pair 6/*genetics | 3 | 2.0 |
Lymphoma, Follicular/*genetics | 2 | 10.0 |
Restriction Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 14/genetics | 6 | 7.0 |
Chromosomes, Human, Pair 18/genetics | 3 | 6.0 |
Lymphoma, Follicular/genetics/metabolism/*pathology | 2 | 66.0 |
Neprilysin/analysis | 2 | 3.0 |
Proto-Oncogene Proteins c-bcl-2/analysis | 2 | 1.0 |
Translocation, Genetic | 16 | 2.0 |
*Genes, Immunoglobulin | 3 | 1.0 |
Interphase | 4 | 2.0 |
*Oncogenes | 5 | 1.0 |
*Chromosomes, Human, Pair 3 | 13 | 3.0 |
Gene Rearrangement | 16 | 3.0 |
*Immunologic Memory | 2 | 1.0 |
Neprilysin/metabolism | 2 | 16.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Survival Analysis | 5 | 0.0 |
5' Untranslated Regions | 2 | 1.0 |
DNA Primers | 3 | 0.0 |
Lymphoma, Non-Hodgkin/*genetics | 6 | 14.0 |
B-Lymphocytes/pathology | 4 | 4.0 |
Disease-Free Survival | 2 | 0.0 |
COS Cells | 5 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Chromosome Deletion | 4 | 0.0 |
DNA, Neoplasm/genetics | 4 | 0.0 |
Chromosomes, Human, Pair 3/genetics | 4 | 3.0 |
Translocation, Genetic/genetics | 2 | 2.0 |
Microscopy, Confocal | 2 | 0.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
*Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Zinc Fingers/genetics | 3 | 1.0 |
B-Lymphocytes/*pathology | 2 | 4.0 |
Diagnosis, Differential | 3 | 0.0 |
*Mutation | 6 | 0.0 |
*Genes, myc | 3 | 1.0 |
DNA, Neoplasm/analysis | 5 | 0.0 |
Tumor Markers, Biological/analysis | 3 | 0.0 |
Exons | 2 | 0.0 |
Immunoglobulins/*genetics | 2 | 4.0 |
Flow Cytometry | 2 | 0.0 |
*Gene Rearrangement, B-Lymphocyte | 2 | 7.0 |
Genes, bcl-2 | 3 | 2.0 |
Genes, myc | 4 | 1.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Hela Cells | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 4 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
*Gene Amplification | 2 | 0.0 |
Polymerase Chain Reaction/methods | 5 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Antigens, CD/genetics | 2 | 1.0 |
Lymphoma, B-Cell/*metabolism/pathology | 2 | 13.0 |
Up-Regulation | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Lymphoma, B-Cell/genetics/*pathology | 2 | 20.0 |
Chromosomes, Human, Pair 14 | 4 | 2.0 |
*Genes, bcl-2 | 3 | 4.0 |
DNA, Neoplasm | 2 | 1.0 |
Genes, Immunoglobulin | 5 | 2.0 |
DNA-Binding Proteins/genetics/*physiology | 3 | 1.0 |
Proto-Oncogene Proteins/genetics/*physiology | 3 | 3.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
Templates, Genetic | 2 | 1.0 |
*Transcription, Genetic | 4 | 0.0 |
Chromosomes, Human, Pair 3 | 6 | 3.0 |
Lymphocytes/*pathology | 2 | 4.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Chromosomes, Human, Pair 18 | 3 | 2.0 |
Gene Rearrangement, B-Lymphocyte | 3 | 5.0 |
Cell Division | 4 | 0.0 |
*Proto-Oncogenes | 7 | 1.0 |
Zinc Fingers/*genetics | 2 | 1.0 |
DNA Mutational Analysis | 5 | 0.0 |
Gene Expression Regulation, Neoplastic/genetics | 2 | 1.0 |
Chromosome Aberrations/*genetics | 2 | 1.0 |
Alleles | 4 | 0.0 |
Neoplasm Proteins/biosynthesis/genetics | 2 | 1.0 |
Remission Induction | 2 | 0.0 |
Lymphoma, Large-Cell, Diffuse/genetics/pathology | 2 | 50.0 |
Cell Line, Transformed | 2 | 0.0 |
Repressor Proteins/*metabolism | 3 | 1.0 |
Chromosomes, Human, Pair 14/*genetics | 2 | 2.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Antigens, Neoplasm/analysis | 2 | 0.0 |
DNA-Binding Proteins/analysis/*genetics | 2 | 6.0 |
Proto-Oncogene Proteins/analysis/*genetics | 2 | 4.0 |
Transcription Factors/analysis/*genetics | 2 | 6.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
Cyclin D1 | 2 | 1.0 |
Cyclins/genetics | 2 | 1.0 |
Oncogene Proteins/genetics | 2 | 2.0 |
*Chromosome Deletion | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Trisomy | 2 | 1.0 |
DNA/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Bone Marrow/pathology | 2 | 0.0 |
*Chromosomes, Human, Pair 14 | 3 | 1.0 |
Mice, Inbred DBA | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2 | 2 | 1.0 |
Child, Preschool | 3 | 0.0 |
Genes, Immunoglobulin/genetics | 2 | 8.0 |
Infant | 3 | 0.0 |
Organ Transplantation/*adverse effects | 2 | 18.0 |
Phenotype | 2 | 0.0 |
Aneuploidy | 2 | 1.0 |
Point Mutation | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Introns | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
B-Lymphocytes/*metabolism | 2 | 1.0 |
*Chromosome Breakage | 2 | 5.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Somatic Hypermutation, Immunoglobulin | 2 | 20.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Mice, Congenic | 2 | 12.0 |
Neprilysin/*metabolism | 2 | 14.0 |
Germinal Center/pathology | 2 | 25.0 |
Molecular Diagnostic Techniques | 2 | 10.0 |
